Taken together, our data demonstrate that miRNAs modulate CKS1B gains and expression in vitro and show an association in vivo, which provides another mechanism for increased levels of this oncogene that may contribute to resistance to cisplatin and other drugs in cancer. The gene discussed is CKS1B; the disease is cancer.